SlideShare uma empresa Scribd logo
1 de 1
Baixar para ler offline
Summary of Pharmacovigilance (PV) Expertise and Experience
Department
startup & strategic
process
improvement:
 PV department design, job descriptions, and outsourcing strategy
 Establishment of PV internal interfaces (e.g., Clinical, Medical
Affairs, Marketing, HOER, Quality) and safety governance, call
center start up
 Adverse event collection, processing, and reporting procedures
 Process improvement and tools for case management,
PBRER/DSUR development
 Risk management plan integration
Global expansion/
product launch:
 Cross-departmental gap analysis and implementation of global
regulations including EMA GVP
 Affiliate PV department creation including allocation of PV tasks,
integration with headquarters (HQ), SOP strategy, and call center
selection and start up
PV quality system:  SOP strategy, development, and training
 Inspection readiness evaluation, preparation, and site support
 PV department, call center, and vendor audits
 CAPA root cause analysis, remediation, and management
 Compliance and quality metrics for ICSRs and periodic reports
License partner
liaison:
 Standard Safety Data Exchange Agreement (SDEA) templates
 SDEA negotiation, finalization, and implementation
 License partner management and compliance monitoring
Outsourcing:  Outsourcing strategy, RFP development, and vendor selection
 Vendor start up and on-going management
 Tools for ICSR and periodic report quality management
Clinical and post-
marketing
programs:
 Safety reporting requirements definition and standard language for
protocols, investigator-initiated research (IIR), and vendor contracts
 Safety Management Plan templates and documentation of PV
responsibilities and flow of safety information for study start-up
PV operations
project
management:
 Business requirements for database selection, customization and/or
configuration; database implementation project management
 Manage PBRER/DSUR development

Mais conteúdo relacionado

Mais procurados

Program for Supporting Reps
Program for Supporting RepsProgram for Supporting Reps
Program for Supporting RepsPhil Heft
 
2nd exl Quality Oversight Conf Szpindor In Process Vendor Audit
2nd exl Quality Oversight Conf   Szpindor In Process Vendor Audit2nd exl Quality Oversight Conf   Szpindor In Process Vendor Audit
2nd exl Quality Oversight Conf Szpindor In Process Vendor AuditStan Szpindor
 
Risk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesRisk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesWool Consuting Group Inc.
 
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
 
Managing Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical TrialsManaging Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical TrialsThe Avoca Group
 
QA Test Status Report Template
QA Test Status Report TemplateQA Test Status Report Template
QA Test Status Report TemplatePrice Charlot
 
How to Measure Outcomes in Addiction Treatment
How to Measure Outcomes in Addiction TreatmentHow to Measure Outcomes in Addiction Treatment
How to Measure Outcomes in Addiction Treatmentesqentrepreneur
 
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based MonitoringBioclinica
 
Improving Patient Satisfaction with Bellwether
Improving Patient Satisfaction with BellwetherImproving Patient Satisfaction with Bellwether
Improving Patient Satisfaction with BellwetherBrian Lee Csp
 
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...Covance
 
e-Zest Solutions Inc. - Testing (Healthcare Domain) Competency
e-Zest Solutions Inc. - Testing (Healthcare Domain) Competencye-Zest Solutions Inc. - Testing (Healthcare Domain) Competency
e-Zest Solutions Inc. - Testing (Healthcare Domain) CompetencySatish Agrawal
 
EXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumEXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumThe Avoca Group
 
Implementing MDSAP (Medical Device Single Audit Program) for Compliance Success
Implementing MDSAP (Medical Device Single Audit Program) for Compliance SuccessImplementing MDSAP (Medical Device Single Audit Program) for Compliance Success
Implementing MDSAP (Medical Device Single Audit Program) for Compliance SuccessGlobalCompliancePanel
 
David cocker feasibility_and_web_mining
David cocker feasibility_and_web_miningDavid cocker feasibility_and_web_mining
David cocker feasibility_and_web_miningDavid Cocker
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineGRCTS
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalManjusha Chowdhury
 

Mais procurados (20)

Program for Supporting Reps
Program for Supporting RepsProgram for Supporting Reps
Program for Supporting Reps
 
2nd exl Quality Oversight Conf Szpindor In Process Vendor Audit
2nd exl Quality Oversight Conf   Szpindor In Process Vendor Audit2nd exl Quality Oversight Conf   Szpindor In Process Vendor Audit
2nd exl Quality Oversight Conf Szpindor In Process Vendor Audit
 
Risk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on SitesRisk Based Monitoring in Clinical Trials - Impact on Sites
Risk Based Monitoring in Clinical Trials - Impact on Sites
 
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...
 
PV Audit
PV AuditPV Audit
PV Audit
 
Managing Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical TrialsManaging Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical Trials
 
QA Test Status Report Template
QA Test Status Report TemplateQA Test Status Report Template
QA Test Status Report Template
 
How to Measure Outcomes in Addiction Treatment
How to Measure Outcomes in Addiction TreatmentHow to Measure Outcomes in Addiction Treatment
How to Measure Outcomes in Addiction Treatment
 
CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.
 
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
3 Reasons Intelligent Monitoring Outperforms Risk-Based Monitoring
 
Improving Patient Satisfaction with Bellwether
Improving Patient Satisfaction with BellwetherImproving Patient Satisfaction with Bellwether
Improving Patient Satisfaction with Bellwether
 
MU3- Through Nalashaa’s lenses
MU3- Through Nalashaa’s lensesMU3- Through Nalashaa’s lenses
MU3- Through Nalashaa’s lenses
 
Webinar on Risk Management in Clinical
Webinar on Risk Management in ClinicalWebinar on Risk Management in Clinical
Webinar on Risk Management in Clinical
 
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...
 
e-Zest Solutions Inc. - Testing (Healthcare Domain) Competency
e-Zest Solutions Inc. - Testing (Healthcare Domain) Competencye-Zest Solutions Inc. - Testing (Healthcare Domain) Competency
e-Zest Solutions Inc. - Testing (Healthcare Domain) Competency
 
EXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight ForumEXL Clinical Quality Oversight Forum
EXL Clinical Quality Oversight Forum
 
Implementing MDSAP (Medical Device Single Audit Program) for Compliance Success
Implementing MDSAP (Medical Device Single Audit Program) for Compliance SuccessImplementing MDSAP (Medical Device Single Audit Program) for Compliance Success
Implementing MDSAP (Medical Device Single Audit Program) for Compliance Success
 
David cocker feasibility_and_web_mining
David cocker feasibility_and_web_miningDavid cocker feasibility_and_web_mining
David cocker feasibility_and_web_mining
 
Clinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guidelineClinical evaluation and the latest 2016 guideline
Clinical evaluation and the latest 2016 guideline
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
 

Destaque

J manning potts-selecoes_das_cartas_de_joao_wesley (4)
J manning potts-selecoes_das_cartas_de_joao_wesley (4)J manning potts-selecoes_das_cartas_de_joao_wesley (4)
J manning potts-selecoes_das_cartas_de_joao_wesley (4)Luiza Dayana
 
Dewey_Sticker_Idea_3_Final
Dewey_Sticker_Idea_3_FinalDewey_Sticker_Idea_3_Final
Dewey_Sticker_Idea_3_FinalAna Medvedeva
 
Automation testing
Automation testingAutomation testing
Automation testing99tests
 
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”Lan Liu
 
Expresión de las emociones
Expresión de las emocionesExpresión de las emociones
Expresión de las emocionesespartero_pucela
 
Earwaks Interview - J.Hunsberger
Earwaks Interview - J.HunsbergerEarwaks Interview - J.Hunsberger
Earwaks Interview - J.HunsbergerBrandon Sweet
 
Civilizacija Inka
Civilizacija InkaCivilizacija Inka
Civilizacija InkaRenata Mnc
 
Prova2la pau
Prova2la pauProva2la pau
Prova2la paujosems50
 
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...Lightspeed
 
The effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing lossThe effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing lossmphaliuj
 
Animais do pantanal ameaçados de extinção
Animais do pantanal ameaçados de extinçãoAnimais do pantanal ameaçados de extinção
Animais do pantanal ameaçados de extinçãoescolanilce
 
Convento de Mafra
Convento de MafraConvento de Mafra
Convento de MafraJoão Couto
 

Destaque (20)

Final
FinalFinal
Final
 
shuvro_CM_4x
shuvro_CM_4xshuvro_CM_4x
shuvro_CM_4x
 
J manning potts-selecoes_das_cartas_de_joao_wesley (4)
J manning potts-selecoes_das_cartas_de_joao_wesley (4)J manning potts-selecoes_das_cartas_de_joao_wesley (4)
J manning potts-selecoes_das_cartas_de_joao_wesley (4)
 
Photography
PhotographyPhotography
Photography
 
Album de fotos
Album de fotosAlbum de fotos
Album de fotos
 
Dewey_Sticker_Idea_3_Final
Dewey_Sticker_Idea_3_FinalDewey_Sticker_Idea_3_Final
Dewey_Sticker_Idea_3_Final
 
Automation testing
Automation testingAutomation testing
Automation testing
 
JFK.PDF
JFK.PDFJFK.PDF
JFK.PDF
 
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”
The suspicious finger of fake wine points to whom?是谁打翻了波尔多的“醋”
 
Expresión de las emociones
Expresión de las emocionesExpresión de las emociones
Expresión de las emociones
 
Earwaks Interview - J.Hunsberger
Earwaks Interview - J.HunsbergerEarwaks Interview - J.Hunsberger
Earwaks Interview - J.Hunsberger
 
Civilizacija Inka
Civilizacija InkaCivilizacija Inka
Civilizacija Inka
 
2009
20092009
2009
 
Prova2la pau
Prova2la pauProva2la pau
Prova2la pau
 
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...
Lightspeed Connect - Niels de Peuter - Mempay - "Hoe kan ik een abonnementsmo...
 
The effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing lossThe effects of tuberculosis and hearing loss
The effects of tuberculosis and hearing loss
 
Ed Clarice Lispector Ecoville
Ed Clarice  Lispector EcovilleEd Clarice  Lispector Ecoville
Ed Clarice Lispector Ecoville
 
Animais do pantanal ameaçados de extinção
Animais do pantanal ameaçados de extinçãoAnimais do pantanal ameaçados de extinção
Animais do pantanal ameaçados de extinção
 
Convento de Mafra
Convento de MafraConvento de Mafra
Convento de Mafra
 
Polish customs
Polish customsPolish customs
Polish customs
 

Semelhante a Pharmacovigilance Expertise Summary for Startups and Strategic Process Improvement

“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...Marcep Inc.
 
Quality Darral Addison format 01112016
Quality Darral Addison format 01112016Quality Darral Addison format 01112016
Quality Darral Addison format 01112016larrad2
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation CHUAN YAO
 
Avoca 2014 DIA Presentation
Avoca 2014 DIA PresentationAvoca 2014 DIA Presentation
Avoca 2014 DIA PresentationThe Avoca Group
 
Cphq course
Cphq courseCphq course
Cphq courseAli Cphq
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureGRCTS
 
Partnerships in Clinical Trials 2014
Partnerships in Clinical Trials 2014Partnerships in Clinical Trials 2014
Partnerships in Clinical Trials 2014The Avoca Group
 
RIMS and its significance for IDMP
RIMS and its significance for IDMPRIMS and its significance for IDMP
RIMS and its significance for IDMPVinayak Andhale
 
Transforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically DrivenTransforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically DrivenVeeva Systems
 
Computer system validation course pdf september 2017
Computer system validation course   pdf september 2017Computer system validation course   pdf september 2017
Computer system validation course pdf september 2017GlobalCompliancePanel
 
C3Africa Audit Presentation
C3Africa Audit PresentationC3Africa Audit Presentation
C3Africa Audit PresentationC3Africa
 
Effective medical device validation introduction manual advance
Effective medical device validation introduction   manual advanceEffective medical device validation introduction   manual advance
Effective medical device validation introduction manual advanceguest2d7d1cac
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Holly Devine
 
FDA News Presentation
FDA News PresentationFDA News Presentation
FDA News PresentationBoris Videlov
 
Build in quality +
Build in quality +Build in quality +
Build in quality +njjensen
 

Semelhante a Pharmacovigilance Expertise Summary for Startups and Strategic Process Improvement (20)

“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
 
Quality Darral Addison format 01112016
Quality Darral Addison format 01112016Quality Darral Addison format 01112016
Quality Darral Addison format 01112016
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation
 
Avoca 2014 DIA Presentation
Avoca 2014 DIA PresentationAvoca 2014 DIA Presentation
Avoca 2014 DIA Presentation
 
Cphq course
Cphq courseCphq course
Cphq course
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to Closure
 
CV
CVCV
CV
 
Partnerships in Clinical Trials 2014
Partnerships in Clinical Trials 2014Partnerships in Clinical Trials 2014
Partnerships in Clinical Trials 2014
 
RIMS and its significance for IDMP
RIMS and its significance for IDMPRIMS and its significance for IDMP
RIMS and its significance for IDMP
 
Transforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically DrivenTransforming Pharmacovigilance from Operational to Scientifically Driven
Transforming Pharmacovigilance from Operational to Scientifically Driven
 
Denise Mauro's CV
Denise Mauro's CVDenise Mauro's CV
Denise Mauro's CV
 
Annex-1
Annex-1Annex-1
Annex-1
 
Computer system validation course pdf september 2017
Computer system validation course   pdf september 2017Computer system validation course   pdf september 2017
Computer system validation course pdf september 2017
 
DOC-20160808-WA0000
DOC-20160808-WA0000DOC-20160808-WA0000
DOC-20160808-WA0000
 
C3Africa Audit Presentation
C3Africa Audit PresentationC3Africa Audit Presentation
C3Africa Audit Presentation
 
Effective medical device validation introduction manual advance
Effective medical device validation introduction   manual advanceEffective medical device validation introduction   manual advance
Effective medical device validation introduction manual advance
 
Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6Ashfield PV Services_Trifold v6
Ashfield PV Services_Trifold v6
 
FDA News Presentation
FDA News PresentationFDA News Presentation
FDA News Presentation
 
Build in quality +
Build in quality +Build in quality +
Build in quality +
 

Pharmacovigilance Expertise Summary for Startups and Strategic Process Improvement

  • 1. Summary of Pharmacovigilance (PV) Expertise and Experience Department startup & strategic process improvement:  PV department design, job descriptions, and outsourcing strategy  Establishment of PV internal interfaces (e.g., Clinical, Medical Affairs, Marketing, HOER, Quality) and safety governance, call center start up  Adverse event collection, processing, and reporting procedures  Process improvement and tools for case management, PBRER/DSUR development  Risk management plan integration Global expansion/ product launch:  Cross-departmental gap analysis and implementation of global regulations including EMA GVP  Affiliate PV department creation including allocation of PV tasks, integration with headquarters (HQ), SOP strategy, and call center selection and start up PV quality system:  SOP strategy, development, and training  Inspection readiness evaluation, preparation, and site support  PV department, call center, and vendor audits  CAPA root cause analysis, remediation, and management  Compliance and quality metrics for ICSRs and periodic reports License partner liaison:  Standard Safety Data Exchange Agreement (SDEA) templates  SDEA negotiation, finalization, and implementation  License partner management and compliance monitoring Outsourcing:  Outsourcing strategy, RFP development, and vendor selection  Vendor start up and on-going management  Tools for ICSR and periodic report quality management Clinical and post- marketing programs:  Safety reporting requirements definition and standard language for protocols, investigator-initiated research (IIR), and vendor contracts  Safety Management Plan templates and documentation of PV responsibilities and flow of safety information for study start-up PV operations project management:  Business requirements for database selection, customization and/or configuration; database implementation project management  Manage PBRER/DSUR development